ArticleOncotarget2016

Simm530, a novel and highly selective c-Met inhibitor, blocks c-Met-stimulated signaling and neoplastic activities.

Ying Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.